These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 307940)

  • 1. Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1978 Jun; 13(6):969-70. PubMed ID: 307940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of rifampin-resistant Haemophilus influenzae.
    Nicolle LE; Postl B; Kotelewetz E; Albritton W; Harding GK; Bourgault AM; Ronald AR
    Antimicrob Agents Chemother; 1982 Mar; 21(3):498-500. PubMed ID: 6980623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The susceptibility of Haemophilus influenzae middle ear and sinus isolates to sulphisoxazole.
    Sheeran PW; Smith AL; Mendelman PL
    J Antimicrob Chemother; 1994 Feb; 33(2):360-3. PubMed ID: 8182026
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.
    Jadavji T; Prober CG; Cheung R
    Antimicrob Agents Chemother; 1984 Jul; 26(1):91-3. PubMed ID: 6332573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampin on nasopharyngeal carriage of Haemophilus influenzae type b.
    Yogev R; Lander HB; Davis AT
    J Pediatr; 1979 May; 94(5):840-1. PubMed ID: 312927
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.
    Yogev R; Melick C; Glogowski W
    Antimicrob Agents Chemother; 1982 Mar; 21(3):387-9. PubMed ID: 6980621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disc inhibition zones of rifampin against Haemophilus influenzae type b.
    Walterspiel JN; Mason EO; Kaplan SL
    Pediatr Infect Dis; 1985; 4(2):209-10. PubMed ID: 3872446
    [No Abstract]   [Full Text] [Related]  

  • 8. Statewide survey of the antimicrobial susceptibilities of Haemophilus influenzae producing invasive disease in Tennessee.
    Gustafson TL; Kelley RA; Hutcheson RH; Schaffner W; Sell SH
    Pediatr Infect Dis; 1983; 2(2):119-22. PubMed ID: 6602329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation frequency of Haemophilus influenzae to rifampin resistance.
    Mendelman PM; Roberts MC; Smith AL
    Antimicrob Agents Chemother; 1982 Sep; 22(3):531-3. PubMed ID: 6982682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
    Doern GV; Jorgensen JH; Thornsberry C; Preston DA; Tubert T; Redding JS; Maher LA
    Antimicrob Agents Chemother; 1988 Feb; 32(2):180-5. PubMed ID: 3259121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Hemophilus influenzae.
    McLinn SE; Nelson JD; Haltalin KC
    Pediatrics; 1970 May; 45(5):827-38. PubMed ID: 5309847
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis.
    Murphy TV; McCracken GH; Zweighaft TC; Hansen EJ
    J Pediatr; 1981 Sep; 99(3):406-9. PubMed ID: 6973618
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.
    McDougal LK; Thornsberry C
    J Antimicrob Chemother; 1982 May; 9(5):369-78. PubMed ID: 6980217
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic susceptibility of Haemophilus influenzae isolated from cerebrospinal fluid and blood.
    Arpi M; Hønberg PZ; Frimodt-Møller N
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):167-71. PubMed ID: 3488639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
    Mortensen JE; LaRocco M; Himes SL; Inderlied C; Daly JA; Campos JM; Mendelman PM
    Diagn Microbiol Infect Dis; 1990; 13(4):341-4. PubMed ID: 2076596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Diplococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis to 23 antibiotics.
    Sabath LD; Stumpf LL; Wallace SJ; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():53-6. PubMed ID: 4398824
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b.
    Gordon RC; Wofford-McQueen R; Shu K
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):201-5. PubMed ID: 2338089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin-sulfisoxazole for persistent acute otitis media due to ampicillin-resistant Haemophilus influenzae.
    Rodriguez WJ; Schwartz RH; Khan WN; Gold AJ
    Pediatr Infect Dis; 1983; 2(1):27-9. PubMed ID: 6601265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for gene silencing in Haemophilus influenzae.
    Setlow JK; Albritton WL; Cabrera-Juárez E
    Mutat Res; 2001 Jul; 478(1-2):65-74. PubMed ID: 11406170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among invasive Haemophilus influenzae strains: results of a Brazilian study carried out from 1996 through 2000.
    Casagrande ST; Landgraf IM; Kobata AM; Zanella RC; Bokermann S
    Braz J Med Biol Res; 2002 Nov; 35(11):1293-300. PubMed ID: 12426628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.